Bio-Techne Corp (NAS:TECH)
$ 72.14 +0.040 (+0.06%) Market Cap: 11.24 Bil Enterprise Value: 11.32 Bil PE Ratio: 104.55 PB Ratio: 5.42 GF Score: 88/100

Bio-Techne Corp at Bank of America Global Healthcare Conference Transcript

May 12, 2026 / 04:20PM GMT
Release Date Price: $47.42
Michael Ryskin
Bank of America - Analyst

My name is Mike Ryskin. I'm one the Bank of America Life Science Tools and Diagnostics team. And we're excited to be joined by Bio-Techne. We're pleased to host Kim Kelderman, Chief Executive Officer; and Jim Hippel, Chief Financial Officer. Kim, Jim, thanks for being here.

James Hippel
Bio-Techne Corp - Chief Financial Officer, Executive Vice President - Finance

Great. Thanks for having us.

Questions & Answers

Michael Ryskin
Bank of America - Analyst

Format will be a fireside chat, but raise your hand if you've got a burning question. I mean maybe just to kick things off, you recently reported. Any highlights from the quarter. You talk through sort of how it played out relative to expectations? What was a little bit better?

What was a little bit worse?

Kim Kelderman
Bio-Techne Corp - President - Diagnostics and Genomics

Yes. So yes, we reported and printed negative 2% growth for the quarter, and that was

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot